These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22898483)

  • 1. A new perspective to determine the severity of cases with Crimean-Congo hemorrhagic fever.
    Bakir M; Engin A; Gozel MG; Elaldi N; Kilickap S; Cinar Z
    J Vector Borne Dis; 2012 Jun; 49(2):105-10. PubMed ID: 22898483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a severity grading score (SGS) system for predicting the course of disease and mortality in patients with Crimean-Congo hemorrhagic fever (CCHF).
    Bakır M; Gözel MG; Köksal I; Aşık Z; Günal Ö; Yılmaz H; But A; Yılmaz G; Engin A
    Eur J Clin Microbiol Infect Dis; 2015 Feb; 34(2):325-30. PubMed ID: 25213721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severity scoring index for Crimean-Congo hemorrhagic fever and the impact of ribavirin and corticosteroids on fatality.
    Dokuzoguz B; Celikbas AK; Gök ŞE; Baykam N; Eroglu MN; Ergönül Ö
    Clin Infect Dis; 2013 Nov; 57(9):1270-4. PubMed ID: 23946218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does electrocardiography at admission predict outcome in Crimean -Congo hemorrhagic fever?
    Yilmaz MB; Engin A; Bektasoglu G; Zorlu A; Ege MR; Bakir M; Dokmetas I
    J Vector Borne Dis; 2011 Sep; 48(3):150-4. PubMed ID: 21946714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of clinical and laboratory predictors of fatality in patients with Crimean-Congo haemorrhagic fever in a tertiary care hospital in Turkey.
    Hatipoglu CA; Bulut C; Yetkin MA; Ertem GT; Erdinc FS; Kilic EK; Sari T; Kinikli S; Oral B; Demiroz AP
    Scand J Infect Dis; 2010 Jul; 42(6-7):516-21. PubMed ID: 20166862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the relationship between serum levels of VEGF and sVEGFR1 with mortality and prognosis in patients with Crimean-Congo hemorrhagic fever.
    Bakir M; Bakir S; Sari I; Celik VK; Gozel MG; Engin A
    J Med Virol; 2013 Oct; 85(10):1794-801. PubMed ID: 23868816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness of routine laboratory findings in determining disease severity in patients with Crimean-Congo hemorrhagic fever: severity prediction criteria.
    Yilmaz G; Koksal I; Topbas M; Yilmaz H; Aksoy F
    J Clin Virol; 2010 Apr; 47(4):361-5. PubMed ID: 20149724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the association of serum levels of hyaluronic acid, sICAM-1, sVCAM-1, and VEGF-A with mortality and prognosis in patients with Crimean-Congo hemorrhagic fever.
    Ozturk B; Kuscu F; Tutuncu E; Sencan I; Gurbuz Y; Tuzun H
    J Clin Virol; 2010 Feb; 47(2):115-9. PubMed ID: 20005156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine levels in Crimean-Congo hemorrhagic fever.
    Papa A; Bino S; Velo E; Harxhi A; Kota M; Antoniadis A
    J Clin Virol; 2006 Aug; 36(4):272-6. PubMed ID: 16765637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of vascular endothelial damage in Crimean-Congo hemorrhagic fever.
    Bodur H; Akinci E; Ongürü P; Uyar Y; Baştürk B; Gözel MG; Kayaaslan BU
    Int J Infect Dis; 2010 Aug; 14(8):e704-7. PubMed ID: 20627646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased serum ferritin levels in patients with Crimean-Congo hemorrhagic fever: can it be a new severity criterion?
    Barut S; Dincer F; Sahin I; Ozyurt H; Akkus M; Erkorkmaz U
    Int J Infect Dis; 2010 Jan; 14(1):e50-4. PubMed ID: 19487150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can the mild clinical course of crimean-congo hemorrhagic fever in children be explained by cytokine responses?
    Ozsurekci Y; Arasli M; Karadag Oncel E; Caglayik DY; Kaya A; Icagasioglu FD; Engin A; Korukluoglu G; Elaldi N; Ceyhan M
    J Med Virol; 2013 Nov; 85(11):1955-9. PubMed ID: 23893846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct healthcare costs for patients hospitalized with Crimean-Congo haemorrhagic fever can be predicted by a clinical illness severity scoring system.
    Bozkurt I; Sunbul M; Yilmaz H; Esen S; Leblebicioglu H; Beeching NJ
    Pathog Glob Health; 2016; 110(1):9-13. PubMed ID: 27077310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral load as a predictor of outcome in Crimean-Congo hemorrhagic fever.
    Cevik MA; Erbay A; Bodur H; Eren SS; Akinci E; Sener K; Ongürü P; Kubar A
    Clin Infect Dis; 2007 Oct; 45(7):e96-100. PubMed ID: 17806044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crimean-Congo hemorrhagic fever disease due to tick bite with very long incubation periods.
    Kaya A; Engin A; Güven AS; Içağasıoğlu FD; Cevit O; Elaldı N; Gültürk A
    Int J Infect Dis; 2011 Jul; 15(7):e449-52. PubMed ID: 21511509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-type natriuretic peptide is associated with the severity of Crimean-Congo hemorrhagic fever.
    Turkdogan KA; Zorlu A; Engin A; Guven FM; Polat MM; Turgut OO; Yilmaz MB
    Int J Infect Dis; 2012 Aug; 16(8):e616-20. PubMed ID: 22695238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of factors predictive of the prognosis in Crimean-Congo hemorrhagic fever: new suggestions.
    Ozturk B; Tutuncu E; Kuscu F; Gurbuz Y; Sencan I; Tuzun H
    Int J Infect Dis; 2012 Feb; 16(2):e89-93. PubMed ID: 22154082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of plasma cell-free DNA level with mortality and prognosis in patients with Crimean-Congo hemorrhagic fever.
    Bakir M; Engin A; Kuskucu MA; Bakir S; Gündag O; Midilli K
    J Med Virol; 2016 Jul; 88(7):1152-8. PubMed ID: 26680021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors, pathophysiology and novel biomarkers in Crimean-Congo hemorrhagic fever.
    Akinci E; Bodur H; Sunbul M; Leblebicioglu H
    Antiviral Res; 2016 Aug; 132():233-43. PubMed ID: 27378224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic value of Ischemia-modified albumin in patients with Crimean-Congo hemorrhagic fever.
    Mentese A; Koksal I; Sumer AU; Arslan M; Karahan SC; Yılmaz G
    J Med Virol; 2013 Apr; 85(4):684-8. PubMed ID: 23364834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.